article thumbnail

mophie Acquired By ZAGG For $100M

socalTECH

According to ZAGG, it will pay $100M, plus earn out, for mophie, creating a new mobile accessory company with 2015 net sales of approximately $470M. The companies did not say how the acquisition would impact mophie's Orange County operations. mophie was led by CEO Daniel Huang. READ MORE>>.

article thumbnail

ResMed Acquires Brightree For $800M

socalTECH

ResMed said it will pay $800M in cash for ResMed, which had net sales of approximately $113M in 2015. San Diego-based medical device provider ResMed has acquired healthcare software developer Brightree , in a deal worth $800M, according to the companies.

San Diego 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NantHealth Files For IPO

socalTECH

NantHealth reported a net loss of $71.6M in total revenues for 2015. NantHealth said it intends to list on the NASDAQ Global Market as NH. The IPO is being underwritten by Jeffries, Cowen and Company, First Analysis Securities Co., The filing is the first IPO filing for a Southern California technology firm so far in 2016.

article thumbnail

OpenX Tops $140M In Revenues

socalTECH

The company also says it has been growing in terms of employees; the company said it had 110 net new hires in 2015, a 31 percent increase in its headcount. OpenX, which is led by Tim Cadogan, said that it saw 40% organic, year-over-year growth and added over 250 publishers during the year.

OpenX 100
article thumbnail

GrubMarket raises $60M as food delivery stays center stage

TechCrunch LA

Past investors also included Y Combinator, where GrubMarket was part of the Winter 2015 cohort), and for some more context, GrubMarket last raised money in April 2019 , $28 million at a $228 million valuation, a source says. It has made some 15 acquisitions in the last two years, including Boston Organics and EJ Food Distributor this year.

article thumbnail

Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy

Xconomy

Pernix Therapeutics is slashing its headcount by more than 20 percent as the specialty pharmaceutical company tries to move toward profitability after a streak of acquisitions. As of the end of 2015, Pernix reported a headcount of 274. Those acquisitions helped Pernix reach $175.8 million net loss.

Sales 40
article thumbnail

LabCorp Boosts Prenatal Testing Presence with $371M Sequenom Deal

Xconomy

LabCorp will also assume net debt of San Diego-based Sequenom (NASDAQ: SQNM ), bringing the value of the cash deal to approximately $371 million. billion in revenue in 2015, most of which came from testing done at physician’s offices and other healthcare facilities. The company’s 2015 revenue was $128.2 LabCorp reported $8.5